Published in J Neuroimmunol on July 01, 1992
Role of interleukin-1beta during pain and inflammation. Brain Res Rev (2008) 1.62
Wallerian degeneration: the innate-immune response to traumatic nerve injury. J Neuroinflammation (2011) 1.41
The neuroprotective role of inflammation in nervous system injuries. J Neurol (2004) 1.27
Genetic polymorphisms associated with intervertebral disc degeneration. Spine J (2013) 1.15
ATF3 upregulation in glia during Wallerian degeneration: differential expression in peripheral nerves and CNS white matter. BMC Neurosci (2004) 0.99
Chronic neuropathic pain-like behavior and brain-borne IL-1β. Ann N Y Acad Sci (2012) 0.90
Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol (1996) 0.87
Neurotrauma and inflammation: CNS and PNS responses. Mediators Inflamm (2015) 0.84
Inflammatory profiling of Schwann cells in contact with growing axons distal to nerve injury. Biomed Res Int (2014) 0.79
Corneal Sensitivity and Dry Eye Symptoms in Patients with Keratoconus. PLoS One (2015) 0.77
Synaptic activity and connective tissue remodeling in denervated frog muscle. J Cell Biol (1994) 0.77
[Cytokine regulation and pain. Results of experimental and clinical research]. Schmerz (2008) 0.75
SAPHO syndrome treated with pamidronate: an open-label study of 10 patients. Rheumatology (Oxford) (2004) 1.88
Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene. Ann Rheum Dis (2004) 1.81
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology (1999) 1.49
Screening for prostate cancer. Isr J Med Sci (1995) 1.38
Takayasu's arteritis identified by computerized tomography: revealing the submerged portion of the iceberg? Isr Med Assoc J (1999) 1.38
Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracycline: correlation with inhibition of cytokine secretion. Infect Immun (1996) 1.24
Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis (2010) 1.15
The secretion of PGE2, IL-1 beta, IL-6, and TNF alpha by adherent mononuclear cells from early onset periodontitis patients. J Periodontol (1994) 1.13
Constitutive secretion of interleukin 1 by human monocytes. Eur J Immunol (1983) 1.12
Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol (2001) 1.12
Elevated serum levels of soluble tumour necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol (1992) 1.05
The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J Hum Hypertens (2001) 1.05
Identification of interleukin-2 in human peripheral blood eosinophils. Immunology (1996) 0.99
Plasma inflammatory cytokines correlate to the ovarian hyperstimulation syndrome. Hum Reprod (1996) 0.98
Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril (1997) 0.97
Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1alpha expression. Cancer Res (1999) 0.97
Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival. Br J Cancer (2007) 0.95
Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola. Infect Immun (1999) 0.95
Characterization of intraperitoneal cytokines and nitrites in women with severe ovarian hyperstimulation syndrome. Fertil Steril (1996) 0.94
Establishment of cell lines from somatic cell hybrids between human monocytes and mouse myeloma cells. J Immunol (1984) 0.89
Selection and continuous growth of antigen-specific human T cells by antigen-treated monocytes. Eur J Immunol (1983) 0.87
High oxygen concentration exacerbates cardiopulmonary bypass-induced lung injury. J Cardiothorac Vasc Anesth (2000) 0.86
Cerebrospinal fluid soluble interleukin-2 receptor in cerebral lupus. Br J Rheumatol (1997) 0.86
About colchicine compliance, resistance and virulence. Clin Exp Rheumatol (2009) 0.85
Plasma vascular endothelial growth factor level is a predictor of the severity of postoperative capillary leak syndrome in neonates undergoing cardiopulmonary bypass. Pediatr Surg Int (2002) 0.85
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. Arthritis Rheum (1998) 0.84
Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol (1993) 0.84
Perception of ill spouse and dyadic relationship in couples with affective disorder and those without. J Affect Disord (2000) 0.84
Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10. Immunology (2000) 0.84
Rapid fluorometric quantification of monocyte attachment in tissue culture wells. J Immunol Methods (1993) 0.83
Effects of tetracyclines on the pathologic activity of endotoxin: in vitro and in vivo studies. Adv Dent Res (1998) 0.83
Monoclonal anti-endothelial cell antibodies from a patient with Takayasu arteritis activate endothelial cells from large vessels. Arthritis Rheum (1999) 0.83
Recombinant human interleukin-1 suppresses lipoprotein lipase activity, but not expression of lipoprotein lipase mRNA in mesenchymal rat heart cell cultures. Biochim Biophys Acta (1991) 0.83
Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart (1996) 0.83
Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol (1997) 0.82
Increased levels of basic fibroblast growth factor are found in the cross-clamped heart during cardiopulmonary bypass. Can J Cardiol (2000) 0.82
Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. Exp Hematol (2001) 0.82
Episodic angioedema with eosinophilia: a case associated with T cell activation and cytokine production. Ann Allergy (1993) 0.82
Human monocyte response to cementum extracts from periodontally diseased teeth: effect of conditioning with tetracycline. J Periodontol (1996) 0.82
Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants. J Hematother Stem Cell Res (2001) 0.82
Interleukin 1 inhibitory activity secreted by a human myelomonocytic cell line (M20). Eur J Immunol (1986) 0.81
Parameters affecting the in vitro maturation of human monocytes to macrophages. Int J Cell Cloning (1986) 0.81
Levels of cytokines and collagen type I and type III as a function of age in human gingivitis. J Periodontol (1996) 0.81
Soluble ICAM-1 and E-selectin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Fertil Steril (2001) 0.81
CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients. Fertil Steril (1992) 0.80
Antigen presentation and regulatory functions of human monocytes in the in vitro response of lymphocytes against purified protein derivative of tuberculin (PPD). Eur J Immunol (1981) 0.80
Elevated inflammatory cytokine levels in bone marrow graft rejection. Transplantation (1995) 0.80
Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome? J Reprod Med (1999) 0.80
Interleukin-1 favours the in vitro development of type 2 T helper (Th2) human T-cell clones. Res Immunol (1994) 0.80
Anti-idiotype immunomodulation of experimental anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin Exp Immunol (1999) 0.80
Histamine enhances granulocyte-macrophage colony-stimulating factor and interleukin-6 production by human peripheral blood mononuclear cells. J Leukoc Biol (1995) 0.80
Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNF alpha processing in vitro. J Periodontal Res (1997) 0.80
Cytokines and tumor markers in potentially malignant disorders and oral squamous cell carcinoma: a pilot study. Oral Dis (2013) 0.79
The kinetics of leptin in Meigs' syndrome. Gynecol Oncol (2001) 0.79
Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Anticancer Res (2000) 0.79
Bone marrow stromal dysfunction in mice administered cytosine arabinoside. Eur J Haematol (2001) 0.79
Detection of different interleukin-1 activities in human monocytes and monocytic cell lines. J Biol Response Mod (1986) 0.78
Cytokine evaluation in throat infections. Ann Otol Rhinol Laryngol (1998) 0.78
Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behçet disease. Am J Ophthalmol (1997) 0.78
Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation. Leuk Res (1996) 0.78
The prognostic significance of increasing marker levels in metastatic breast cancer patients with clinically complete remission, partial remission or stable disease. Int J Biol Markers (1998) 0.78
Cytokines in experimental autoimmune vasculitis: evidence for a Th2 type response. Clin Exp Rheumatol (1999) 0.78
In vitro proliferation of macrophage depleted human peripheral blood lymphocytes. Clin Exp Immunol (1979) 0.78
Fat necrosis below musculocutaneous flap mimicking carcinoma of breast. Ann Plast Surg (1991) 0.78
Oral tolerance to low dose beta 2-glycoprotein I: immunomodulation of experimental antiphospholipid syndrome. J Immunol (1998) 0.78
Multifocal demyelinative leukoencephalopathy associated with 5-fluorouracil and levamisole. Acta Oncol (2000) 0.77
Low CSF soluble interleukin 2 receptor levels in acute depression. Short communication. J Neural Transm (Vienna) (1999) 0.77
Sequential manifestation of different forms of early-onset periodontitis. A case report. J Periodontol (1994) 0.77
The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J Reprod Immunol (1985) 0.77
Specific in vitro proliferative immune responses and lymphokine production in Ethiopian children with and without tuberculosis. Infection (2000) 0.77
Effect of interleukin-1 on adrenocortical activity in intact and hypothalamic deafferentated male rats. Exp Brain Res (1989) 0.77
The effect of estradiol on human myelomonocytic cells. II. Mechanism of enhancing activity of colony formation. J Reprod Immunol (1986) 0.77
Immunomodulation of murine experimental SLE-like disease by interferon-gamma. Lupus (1998) 0.77
Susceptibility of Legionella pneumophila grown extracellularly and in human monocytes to indole-3-propionic acid. Antimicrob Agents Chemother (1991) 0.76
Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies. Cytokines Cell Mol Ther (1997) 0.76
Cytokine production in human mixed leukocyte reactions performed in serum-free media. J Immunol Methods (1998) 0.76
In vitro differentiation and establishment of cell lines derived from human myelomonocytic leukemia cells. Immunol Lett (1986) 0.76
Solitary nonparasitic cyst of the liver: a rare cause of abdominal distension. Am J Gastroenterol (1989) 0.76
Dysregulation of inflammatory cytokines in unrelated bone marrow transplantation. Cytokines Cell Mol Ther (1998) 0.76
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donors. Leuk Res (1996) 0.75
Symmetry of outcome after photorefractive keratectomy for myopia. J Refract Surg (1995) 0.75
Cytokines and soluble cytokine receptors in Behçet's disease. Isr J Med Sci (1995) 0.75
'Silent' carriage of two familial Mediterranean fever gene mutations in large families with only a single identified patient. Clin Genet (2011) 0.75
Imbalance of immune responses in patients with chronic and widespread fungal skin infection. Clin Exp Dermatol (1995) 0.75
Chronic eosinophilic pneumonia associated with cutaneous T-cell lymphoma. Am J Hematol (1999) 0.75
Regulation of the functional activity of mast cells and fibroblasts by mononuclear cells in murine and human chronic graft-vs.-host disease. Exp Hematol (1997) 0.75
[Male breast cancer]. Harefuah (1989) 0.75
[Clinical applicability of intraperitoneal administration of nutrients and drugs]. Harefuah (1991) 0.75
[Breast cancer and pregnancy]. Harefuah (1989) 0.75
Effect of M20 interleukin-1 inhibitor on normal and leukemic human myeloid progenitors. Blood (1992) 0.75
Bone marrow stromal elements in murine leukemia: decreased CSF-producing fibroblasts and normal IL-1 expression by macrophages. Eur J Haematol (1990) 0.75
Effects of retinoic acid and phorbol ester on lymphocytes and monocytes in B-lymphocytic leukemia. Isr J Med Sci (1989) 0.75
[Appropriate diagnostic steps for proper clinical evaluation of breast lesions in the community]. Harefuah (1991) 0.75
Defective in vitro granulopoiesis in patients with anorexia nervosa. Pediatr Res (1996) 0.75
[Breast developmental disorders and masses in childhood and adolescence]. Harefuah (1991) 0.75
Characterization of human lymphocytes which proliferate "spontaneously" in vitro. Eur J Immunol (1980) 0.75
A new myelomonoblastic cell line (M20): analysis of properties, differentiation, and comparison with other established lines of similar origin. Exp Hematol (1985) 0.75